-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Lowers Price Target to $32

Benzinga·11/24/2025 13:06:06
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Benitec Biopharma (NASDAQ:BNTC) with a Buy and lowers the price target from $35 to $32.